Manage R&D Resources to Increase Productivity
Challenge Our client, a mid-sized pharma company, required inspiration for how best to: Determine and manage the total R&D budget Allocate resources to different R&D activities Use different criteria to prioritise across all phases of R&D from discovery through to brand support Solution We interviewed leaders from innovative pharma companies to generate inspiration for […]
A Robust Partnering Strategy
Challenge A European mid-Pharma company had a gap in its pipeline and was looking for support in forming partnerships to sustain profitable growth in the medium term The BD strategy needed to build upon the company’s recent successful commercialisation of a large molecule and a profitable portfolio of branded mature products Solution Interviewed the Global […]
Agile Operational Governance to Optimise Asset Decision-making
Challenge Changes to the R&D organisational structure and strategic governance process created a need to review and optimise governance at a project level There was appetite to simplify the current R&D operational governance model, reinforce project team empowerment and embed agility within the operational governance model Solution Interviewed more than 40 key stakeholders to […]
Enhancing R&D productivity in MidPharma
On the 24th and 25th April, we had the pleasure of hosting our annual face-to-face MidPharma R&D Symposium in London, the first since the COVID-19 pandemic. The event began with a networking dinner on the evening of the 24th followed by facilitated discussions on the 25th. The symposium was attended by 13 R&D Leaders from […]
What it takes to leverage AI in pharma and biotech R&D
In March 2024 John Rountree, Managing Director of Novasecta, facilitated Chatham-House-Rules discussion for senior executives in the biotech and pharmaceutical sectors, focusing on how firms can make the most of (Artificial Intelligence) AI for their Research and Development (R&D) efforts. This report summarises insights from the workshop. With transparency, realism, and a truly multi-disciplinary and […]
5 Imperatives for Strategic And Operational Excellence: #1 Strategic Focus
Developing and maintaining a sharp strategic focus is a must for strategic and operational excellence in pharma and biotech. In part one of our series ‘The Five Imperatives of Strategic and Operational Excellence’, we explore why strategic focus is important, what good looks like, and how a sharp strategic focus contributes to strategic and operational […]
Novo Nordisk showed ‘extraordinary growth’ but faces competitive weight loss market (CNBC)
John Rountree, Managing Partner at Novasecta, comments on Danish pharma giant Novo Nordisk’s first-quarter earnings. Watch John’s interview here.
Data deals for an AI biotech
Challenge An AI drug discovery biotech sought drug discovery data from both failed and successful assets to train its algorithms. Management wanted to understand MidPharma appetite for and concerns over providing their drug discovery data in creative deal structures, so that it could consider how to further evolve its data strategy. Solution Engaged with the […]